Monday, January 19, 2026 1/19/2026

Molecular mechanisms of host cell escape by Mycobacterium tuberculosis

Award Number: R01AI139492
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/10/2019
PERIOD OF PERFORMANCE END DATE: 06/30/2025

Group Awards By:

View Award Description

Molecular mechanisms of host cell escape by Mycobacterium tuberculosis - Abstract Mycobacterium tuberculosis (Mtb) causes pulmonary tuberculosis (TB) in humans. In 2015 alone,10.4 million new cases were reported, leading to approximately 1.4 million deaths. There are no effective vaccines for TB and only sub-optimal chemotherapeutics exist. Mtb, after a period of intracellular replication and inhibition of host cell apoptosis, leaves the phagosome and triggers cell lysis in order to exit the host cell. There is a gap in our understanding of how Mtb exploits host cell signaling in order to mediate these events. We have discovered a novel transcriptional repressor, Rv3167c, that is important for suppression of phagosomal escape, host cell necrosis and of macroautophagy (autophagy) induction. This activity is mediated via suppression of gene transcription of genes encoding for synthesis and transport of the outer cell membrane lipid phthiocerol dimycocerosates (PDIM). In the current application we propose to utilize a unique set of Mtb mutants discovered in our lab to elucidate the molecular mechanisms of Mtb-mediated host cell necrosis induction. In AIM1 we will characterize the host cell necrosis and autophagy signaling pathways engaged after phagosomal exit of Mtb. AIM1.1. will test how Mtb mediates the regulation of the host kinase AKT. The Aims 1.2 and 1.3 will explore cell signaling events downstream of AKT leading to necrosis or autophagy induction, respectively. These approaches will be used to identify central signaling hubs within the signaling network that will be most interesting for host directed therapeutic approaches. In AIM2 we will characterize the relevance of host cell escape pathway for virulence of Mtb and its potential as a target for therapeutic approaches. In Aim 2.1, knock-out or knock-in mice will be used to corroborate the ex vivo findings of the importance of select host cell signaling proteins during in vivo infection. In Aim 2.2 our discovery of host cell necrosis signaling components will be exploited to test their relevance for Mtb virulence during aerosol infection of mice and thus determine their potential as novel candidates for host-targeted therapeutics using the mouse model of tuberculosis. We believe that our findings will have great translational potential since inhibition of Mtb-mediated necrosis should reduce virulence of the bacteria and decrease host lung pathology.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$130 )
2026	2023	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BUILDING	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Allergy and Infectious Diseases Research	000	5	12/18/2025	NON-COMPETING CONTINUATION	-$130
														Subtotal = -$130

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2023	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BUILDING	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Allergy and Infectious Diseases Research	000	5	11/27/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $615,827 )
2023	2023	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BLDG 7809 REGENTS DR	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Allergy and Infectious Diseases Research	000	5	12/20/2022	NON-COMPETING CONTINUATION	$615,827
														Subtotal = $615,827

Issue Date FY: 2022 ( Subtotal = $615,827 )
2022	2022	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BLDG 7809 REGENTS DR	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Allergy and Infectious Diseases Research	000	4	12/28/2021	NON-COMPETING CONTINUATION	$615,827
														Subtotal = $615,827

Issue Date FY: 2021 ( Subtotal = $608,102 )
2021	2021	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BLDG 7809 REGENTS DR	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Allergy and Infectious Diseases Research	000	3	12/29/2020	NON-COMPETING CONTINUATION	$608,102
														Subtotal = $608,102

Issue Date FY: 2020 ( Subtotal = $656,965 )
2020	2020	UNIVERSITY OF MARYLAND	3112 LEE BLDG 7809 REGENTS DR	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Allergy and Infectious Diseases Research	000	2	1/6/2020	NON-COMPETING CONTINUATION	$656,965
														Subtotal = $656,965

Issue Date FY: 2019 ( Subtotal = $574,452 )
2019	2019	UNIVERSITY OF MARYLAND	3112 LEE BLDG 7809 REGENTS DR	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Allergy and Infectious Diseases Research	000	1	1/8/2019	NEW	$574,452
														Subtotal = $574,452

Grand Total All Awards = $3,071,043

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Molecular mechanisms of host cell escape by Mycobacterium tuberculosis

Award Number: R01AI139492

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/10/2019

PERIOD OF PERFORMANCE END DATE: 06/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer